Search Results
Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Search for other papers by Lisa D Berman-Booty in
Google Scholar
PubMed
Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Search for other papers by Karen E Knudsen in
Google Scholar
PubMed
the major xenograft and genetically engineered mouse models of NePC. We have described the xenograft models and detailed the lesions that the genetically engineered mice develop, their disease progression, and how genetic manipulation of some of these
Search for other papers by Sarah A Dabydeen in
Google Scholar
PubMed
Departments of Oncology, Medicine, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road NW, Research Building, Room 520A, Washington, District of Columbia 20057, USA
Search for other papers by Priscilla A Furth in
Google Scholar
PubMed
commonly ER+ include invasive lobular, papillary, and tubular. Not all of the published studies that report the development of genetically engineered mice provide sufficient detail to be able to definitively assign the histopathology developing in the mouse
Department of Oncology, Georgetown University, Washington, District of Columbia, USA
Search for other papers by Sahar J Alothman in
Google Scholar
PubMed
Search for other papers by Weisheng Wang in
Google Scholar
PubMed
Department of Oncology, Georgetown University, Washington, District of Columbia, USA
Search for other papers by Shan Chao in
Google Scholar
PubMed
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA
Search for other papers by Bhaskar V Kallakury in
Google Scholar
PubMed
College of Pharmacy, Belmont University, Nashville, Tennessee, USA
Search for other papers by Edgar S Díaz-Cruz in
Google Scholar
PubMed
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA
Department of Medicine, Georgetown University, Washington, District of Columbia, USA
Search for other papers by Priscilla A Furth in
Google Scholar
PubMed
Dear Editor, The impact of oral peroxisome proliferator-activated receptor gamma agonist (PPARG) efatutazone exposure through diet on mammary preneoplasia and cancer development was evaluated in genetically engineered mice carrying one vs two
Search for other papers by Caroline Wilson in
Google Scholar
PubMed
Search for other papers by Hannah Brown in
Google Scholar
PubMed
Search for other papers by Ingunn Holen in
Google Scholar
PubMed
proximity to osteoblasts and blood vessels in mouse bone. Genetically engineered mice with GFP-expressing osteoblasts injected via the intracardiac route with CMDii-labelled human MDA-MB-231 cells before sample collection and processing for paraffin sections
Search for other papers by Maho Shibata in
Google Scholar
PubMed
Search for other papers by Michael M Shen in
Google Scholar
PubMed
). Shappell SB Thomas GV Roberts RL Herbert R Ittmann MM Rubin MA Humphrey PA Sundberg JP Rozengurt N Barrios R 2004 Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the
Search for other papers by Estefania Labanca in
Google Scholar
PubMed
CONICET – Universidad de Buenos Aires, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Buenos Aires, Argentina
Search for other papers by Elba S Vazquez in
Google Scholar
PubMed
Search for other papers by Paul G Corn in
Google Scholar
PubMed
Search for other papers by Justin M Roberts in
Google Scholar
PubMed
Search for other papers by Fen Wang in
Google Scholar
PubMed
Search for other papers by Christopher J Logothetis in
Google Scholar
PubMed
Search for other papers by Nora M Navone in
Google Scholar
PubMed
stage of maturation of the target cells, and the microenvironment (e.g. availability of HS). Genetically engineered mice (GEM) studies shed some light on the role of the FGF axis in bone biology. Both genes, Fgfr1 and Fgfr2 , are expressed in the
Search for other papers by Kristen Wong in
Google Scholar
PubMed
Search for other papers by Francesca Di Cristofano in
Google Scholar
PubMed
Search for other papers by Michela Ranieri in
Google Scholar
PubMed
Search for other papers by Daniela De Martino in
Google Scholar
PubMed
Search for other papers by Antonio Di Cristofano in
Google Scholar
PubMed
indicated in Table 1 . Mouse cell lines were established from ATCs developed by genetically engineered mice ( Antico Arciuch et al . 2011 , Dima et al . 2011 ). Cell line identity was validated by STS profiling as well as by amplifying and sequencing
The Ohio State Biochemistry Program, Molecular, Department of Nuclear Medicine, Department of Physiology and Cell Biology, Thyroid Cancer Unit, Center for Biostatistics, Department of Internal Medicine, Cellular and Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio 43210, USA
Search for other papers by Yu-Yu Liu in
Google Scholar
PubMed
The Ohio State Biochemistry Program, Molecular, Department of Nuclear Medicine, Department of Physiology and Cell Biology, Thyroid Cancer Unit, Center for Biostatistics, Department of Internal Medicine, Cellular and Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio 43210, USA
Search for other papers by Michael P Brandt in
Google Scholar
PubMed
Search for other papers by Daniel H Shen in
Google Scholar
PubMed
Search for other papers by Richard T Kloos in
Google Scholar
PubMed
Search for other papers by Xiaoli Zhang in
Google Scholar
PubMed
The Ohio State Biochemistry Program, Molecular, Department of Nuclear Medicine, Department of Physiology and Cell Biology, Thyroid Cancer Unit, Center for Biostatistics, Department of Internal Medicine, Cellular and Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio 43210, USA
The Ohio State Biochemistry Program, Molecular, Department of Nuclear Medicine, Department of Physiology and Cell Biology, Thyroid Cancer Unit, Center for Biostatistics, Department of Internal Medicine, Cellular and Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio 43210, USA
The Ohio State Biochemistry Program, Molecular, Department of Nuclear Medicine, Department of Physiology and Cell Biology, Thyroid Cancer Unit, Center for Biostatistics, Department of Internal Medicine, Cellular and Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio 43210, USA
Search for other papers by Sissy M Jhiang in
Google Scholar
PubMed
-competent genetically engineered mice carrying thyroid tumors surrounded by physiologically/pathologically relevant microenvironment. Our laboratory has previously reported that 17-allyamino-17-demothoxygeldanamycin (17-AAG) increases NIS-mediated radioiodine
Search for other papers by R Serra in
Google Scholar
PubMed
Search for other papers by M R Crowley in
Google Scholar
PubMed
injectable drugs in the treatment of breast cancer with few adverse effects. Summary Genetically engineered mice have been used to determine the role and mechanism of TGF-β signaling in normal breast physiology and pathology. DNA
International Cancer Prevention Institute, Epalinges, Switzerland
Search for other papers by Berna C Özdemir in
Google Scholar
PubMed
Search for other papers by George Sflomos in
Google Scholar
PubMed
ISREC – Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland
Search for other papers by Cathrin Brisken in
Google Scholar
PubMed
Frech SM Nakles RE Diaz-Cruz ES Shiffert MT Furth PA 2012 Association of over-expressed estrogen receptor alpha with development of tamoxifen resistant hyperplasia and adenocarcinomas in genetically engineered mice. Anatomy and Physiology